172 related articles for article (PubMed ID: 9581276)
21. Diversity of lipopolysaccharide structures in Campylobacter jejuni.
Penner JL; Aspinall GO
J Infect Dis; 1997 Dec; 176 Suppl 2():S135-8. PubMed ID: 9396697
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure.
Aspinall GO; Fujimoto S; McDonald AG; Pang H; Kurjanczyk LA; Penner JL
Infect Immun; 1994 May; 62(5):2122-5. PubMed ID: 8168981
[TBL] [Abstract][Full Text] [Related]
23. Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions.
Aspinall GO; Monteiro MA
Biochemistry; 1996 Feb; 35(7):2498-504. PubMed ID: 8652594
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide of Campylobacter coli serotype O:30. Fractionation and structure of liberated core oligosaccharide.
Aspinall GO; McDonald AG; Pang H; Kurjanczyk LA; Penner JL
J Biol Chem; 1993 Mar; 268(9):6263-8. PubMed ID: 8454598
[TBL] [Abstract][Full Text] [Related]
25. Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barré and Miller-Fisher syndromes are of diverse genetic lineage, serotype, and flagella type.
Dingle KE; Van Den Braak N; Colles FM; Price LJ; Woodward DL; Rodgers FG; Endtz HP; Van Belkum A; Maiden MC
J Clin Microbiol; 2001 Sep; 39(9):3346-9. PubMed ID: 11526174
[TBL] [Abstract][Full Text] [Related]
26. The lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B strain NMB contains L2, L3, and novel oligosaccharides, and lacks the lipid-A 4'-phosphate substituent.
Rahman MM; Stephens DS; Kahler CM; Glushka J; Carlson RW
Carbohydr Res; 1998 Feb; 307(3-4):311-24. PubMed ID: 9675370
[TBL] [Abstract][Full Text] [Related]
27. Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide.
Linton D; Karlyshev AV; Hitchen PG; Morris HR; Dell A; Gregson NA; Wren BW
Mol Microbiol; 2000 Mar; 35(5):1120-34. PubMed ID: 10712693
[TBL] [Abstract][Full Text] [Related]
28. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
Yuki N; Miyatake T
Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
[TBL] [Abstract][Full Text] [Related]
29. Rapid method for sensitive screening of oligosaccharide epitopes in the lipooligosaccharide from Campylobacter jejuni strains isolated from Guillain-Barré syndrome and Miller Fisher syndrome patients.
Dzieciatkowska M; Liu X; Heikema AP; Houliston RS; van Belkum A; Schweda EK; Gilbert M; Richards JC; Li J
J Clin Microbiol; 2008 Oct; 46(10):3429-36. PubMed ID: 18753342
[TBL] [Abstract][Full Text] [Related]
30. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
[TBL] [Abstract][Full Text] [Related]
31. Bacterial infections in Guillain-Barré and Fisher syndromes.
Yuki N; Koga M
Curr Opin Neurol; 2006 Oct; 19(5):451-7. PubMed ID: 16969154
[TBL] [Abstract][Full Text] [Related]
32. Chemical structure of a polysaccharide from Campylobacter jejuni 176.83 (serotype O:41) containing only furanose sugars.
Hanniffy OM; Shashkov AS; Moran AP; Prendergast MM; Senchenkova SN; Knirel YA; Savage AV
Carbohydr Res; 1999 Jun; 319(1-4):124-32. PubMed ID: 10520260
[TBL] [Abstract][Full Text] [Related]
33. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure.
Yuki N; Taki T; Inagaki F; Kasama T; Takahashi M; Saito K; Handa S; Miyatake T
J Exp Med; 1993 Nov; 178(5):1771-5. PubMed ID: 8228822
[TBL] [Abstract][Full Text] [Related]
34. Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh.
Islam Z; van Belkum A; Wagenaar JA; Cody AJ; de Boer AG; Tabor H; Jacobs BC; Talukder KA; Endtz HP
PLoS One; 2009 Sep; 4(9):e7257. PubMed ID: 19789649
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of lipo-oligosaccharide loci of Campylobacter jejuni isolates associated with Guillain-Barré Syndrome from Hebei, China.
Jiang H; Zhang MJ; Liu RC; Tian XY; Gu YX; Zhang JZ
Int J Mol Sci; 2010 Mar; 11(3):1155-61. PubMed ID: 20480006
[TBL] [Abstract][Full Text] [Related]
36. Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides.
Moran AP
J Infect Dis; 1997 Dec; 176 Suppl 2():S115-21. PubMed ID: 9396693
[TBL] [Abstract][Full Text] [Related]
37. Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis.
Godschalk PC; Bergman MP; Gorkink RF; Simons G; van den Braak N; Lastovica AJ; Endtz HP; Verbrugh HA; van Belkum A
BMC Microbiol; 2006 Apr; 6():32. PubMed ID: 16594990
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
Takahashi M; Koga M; Yokoyama K; Yuki N
J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
40. Mass spectrometric analysis of intact lipooligosaccharide: direct evidence for O-acetylated sialic acids and discovery of O-linked glycine expressed by Campylobacter jejuni.
Dzieciatkowska M; Brochu D; van Belkum A; Heikema AP; Yuki N; Houliston RS; Richards JC; Gilbert M; Li J
Biochemistry; 2007 Dec; 46(50):14704-14. PubMed ID: 18034462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
